home / stock / tffp / tffp message board
Subject | By | Source | When |
---|---|---|---|
FORT WORTH, Texas, May 01, 2023 (GLOBE NEWSWIRE) | Paullee | investorshub | 05/01/2023 4:00:16 PM |
Well. That was interesting | derkampfer | investorshub | 02/23/2023 7:10:27 AM |
Anyone here ? Terrible conf call last night | Paullee | investorshub | 02/17/2023 2:42:41 PM |
TFF Pharmaceuticals Announces Collaboration with Aptar Pharma to | Paullee | investorshub | 11/06/2022 2:39:18 PM |
more delays, pretty ugly out there | Paullee | investorshub | 11/02/2022 3:36:16 AM |
Yep. Just waiting on those promised deals by Glenn. | derkampfer | investorshub | 03/26/2022 4:52:44 AM |
anyone here | Paullee | investorshub | 03/17/2022 6:40:06 PM |
From Seeking Alpha | conix | investorshub | 07/27/2021 3:01:14 AM |
News, Short Squeeze, Breakout and More Instantly...
TFF Pharmaceuticals Inc - Ordinary Shares Company Name:
TFFP Stock Symbol:
NYSE Market:
FORT WORTH, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thi...
Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial 6 out of 6 Patients Who Completed the 12-Week Treatment Have Chosen to Remain on TFF TAC by Proceeding to the Safety Extension Phase; 1 patient has been treated for over a year and 3 additional patients ha...
Growing Body of Clinical Data from Ongoing Phase 2 Trial Suggests that Tacrolimus Inhalation Powder (TFF TAC) Could Represent an Important New Innovation for Optimizing Immunosuppressive Therapy in Lung Transplant Recipients Raised $6.0 Million to Support Continued Advancement of TFF TA...